GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
88.20
+2.55 (2.98%)
Nov 21, 2025, 9:54 AM EST - Market open
GRAIL Revenue
GRAIL had revenue of $36.19M in the quarter ending September 30, 2025, with 26.32% growth. This brings the company's revenue in the last twelve months to $141.83M, up 20.53% year-over-year. In the year 2024, GRAIL had annual revenue of $125.60M with 34.90% growth.
Revenue (ttm)
$141.83M
Revenue Growth
+20.53%
P/S Ratio
21.12
Revenue / Employee
$141,827
Employees
1,000
Market Cap
3.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 125.60M | 32.49M | 34.90% |
| Dec 31, 2023 | 93.11M | 37.56M | 67.61% |
| Jan 1, 2023 | 55.55M | 40.94M | 280.17% |
| Jan 2, 2022 | 14.61M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GRAL News
- 2 days ago - GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 7 days ago - Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold - Seeking Alpha
- 8 days ago - GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - GRAIL Reports Third Quarter 2025 Financial Results - PRNewsWire
- 16 days ago - GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference - PRNewsWire
- 16 days ago - Top Biotech Stocks Riding The Rally - Seeking Alpha
- 22 days ago - GRAIL to Announce Third Quarter 2025 Financial Results - PRNewsWire
- 25 days ago - GRAIL: Buy Τhe Test That Could Redefine Cancer Screening - Seeking Alpha